Health - Latest News Search Engine - Global and Local Breaking News

Health

TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster at the 2025 American Society of Clinical Oncology Annual Meeting

Phase 3 IFx-Hu2.0 trial as an adjunctive therapy with Keytruda® (pembrolizumab) in checkpoint inhibitor (CPI)-naïve patients with advanced or metastat...

TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster at the 2025 American Society of Clinical Oncology Annual Meeting

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas...

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

Supplemental Health Care Releases 2025 Impact Report

SALT LAKE CITY, June 2, 2025 /PRNewswire/ -- Supplemental Health Care (SHC) released its 2025 Impact Report, highlighting the organization's ongoing d...

Supplemental Health Care Releases 2025 Impact Report

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO An...

INDIANAPOLIS, June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (...

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufac...

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

Arthrosi Announces Multiple Presentations at the European Alliance of Associations for Rheumatology (EULAR) Congress 2025

SAN DIEGO, June 2, 2025 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly...

Arthrosi Announces Multiple Presentations at the European Alliance of Associations for Rheumatology (EULAR) Congress 2025

Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, L...

MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed P...

$Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions$

Manslaughter case launched into Nottingham baby deaths

A corporate manslaughter investigation has been opened by police as a major review continues.

Manslaughter case launched into Nottingham baby deaths

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial ROCKVILLE, Md., June 2, 2025 /PRNewswire/ --...

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

USANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with Nature

SALT LAKE CITY, June 2, 2025 /PRNewswire/ -- Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals and famil...

USANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with Nature

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further str...

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Grady Launches Emergency Medical Helicopter in Partnership with Air Methods

New air ambulance will enhance trauma response and save lives across the Southeast ATLANTA, June 2, 2025 /PRNewswire/ -- Grady Health System, home to ...

Grady Launches Emergency Medical Helicopter in Partnership with Air Methods

Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic ...

Haduvio met the primary endpoint with statistically-significant reductions in 24-hour cough frequency across all dose groups (108 and 54 mg BID p<0...

Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

– Multiple Subgroup Analyses Presented From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan), Including Data on Lipid and Glycemic Prof...

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

SAN JOSE, Calif., June 2, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on t...

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Terumo Neuro anuncia disponibilidad comercial en EMEA del catéter de aspiración neurovascular SOFIA™ Flow 88

- Ampliación de un legado de ictus: Terumo Neuro anuncia la disponibilidad comercial en EMEA del catéter de aspiración neurovascular SOFIA™ Flow 88 La...

Terumo Neuro anuncia disponibilidad comercial en EMEA del catéter de aspiración neurovascular SOFIA™ Flow 88

TYLENOL® Expands Expertise to Proactive Joint Care with Launch into the Supplement Category

From relief to routine: Proactive Support from the Makers of TYLENOL® delivers clinically backed ingredients that provide effective, drug-free joint s...

TYLENOL® Expands Expertise to Proactive Joint Care with Launch into the Supplement Category

KAHR Bio Announces Positive Phase 2 Results of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer

- Findings presented in an oral presentation at the 2025 ASCO Annual Meeting - DSP107 in combination with atezolizumab in 3rd line microsatellite stab...

KAHR Bio Announces Positive Phase 2 Results of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer

Major study proves exercise improves cancer survival

Risk of dying was cut by a third after colon cancer patients dialled up exercise levels.

Major study proves exercise improves cancer survival

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events

SOUTH SAN FRANCISCO, Calif., June 2, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to ...

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events